Journal of Pharmaceutical and Biomedical Analysis 2010-03-11

Detection of fluorine labeled herceptin using cellular (19)F MRI ex vivo.

Dorota Bartusik, Boguslaw Tomanek

Index: J. Pharm. Biomed. Anal. 51(4) , 894-900, (2010)

Full Text: HTML

Abstract

The aim of this study was to assess the herceptin efficacy in ex vivo cultures of MCF-7 breast carcinoma cells. Herceptin was used with perfluorooctyl bromide (PFOB) and conjugated with lipoplex, containing plasmid DNA and lipofectamine (LipA), to allow fluorine-19 magnetic resonance imaging ((19)F MRI) study. Treatments such as herceptin, herceptin/PFOB and herceptin/PFOB/lipoplex were used for ex vivo targeting of MCF-7 cells cultured in three-dimensional (3D) geometry using hollow fiber bioreactor (HFB) device. The viability of MCF-7 cells after 72h treatments decreased to 54+/-2%, 50+/-3% and 45+/-1% for herceptin, herceptin/PFOB and herceptin/PFOB/Lipoplex, respectively. The EC(50) values were 1000microg/ml, 930microg/ml and 730microg/ml, respectively. The significant correlation between the treatment concentration and efficacy was observed in MCF-7 cell cultures.Crown Copyright 2009. Published by Elsevier B.V. All rights reserved.

Related Compounds

  • PERFLUOROOCT...

Related Articles:

Surfactant and perfluorocarbon aerosolization by means of inhalation catheters for the treatment of respiratory distress syndrome: an in vitro study.

2011-04-01

[J. Aerosol Med. Pulm. Drug Deliv. 24(2) , 81-7, (2011)]

Optimization of perfluoro nano-scale emulsions: The importance of particle size for enhanced oxygen transfer in biomedical applications

2012-10-01

[Colloids Surf. B Biointerfaces 98 , 26-35, (2012)]

Rayleigh theory of ultrasound scattering applied to liquid-filled contrast nanoparticles.

2010-06-07

[Phys. Med. Biol. 55(11) , 3061-76, (2010)]

19F molecular MR imaging for detection of brain tumor angiogenesis: in vivo validation using targeted PFOB nanoparticles.

2013-01-01

[Angiogenesis 16(1) , 171-9, (2013)]

The role of hypoxia in canine cancer.

2008-12-01

[Vet. Comp. Oncol. 6(4) , 213-23, (2008)]

More Articles...